BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33545220)

  • 1. Distinctive role of SIK1 and SIK3 isoforms in aerobic glycolysis and cell growth of breast cancer through the regulation of p53 and mTOR signaling pathways.
    Ponnusamy L; Manoharan R
    Biochim Biophys Acta Mol Cell Res; 2021 Apr; 1868(5):118975. PubMed ID: 33545220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MARK2 potentiate aerobic glycolysis-mediated cell growth in breast cancer through regulating mTOR/HIF-1α and p53 pathways.
    Ponnusamy L; Natarajan SR; Manoharan R
    J Cell Biochem; 2022 Apr; 123(4):759-771. PubMed ID: 35048405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberine and Emodin abrogates breast cancer growth and facilitates apoptosis through inactivation of SIK3-induced mTOR and Akt signaling pathway.
    Ponnusamy L; Kothandan G; Manoharan R
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165897. PubMed ID: 32682817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLC.
    Hollstein PE; Eichner LJ; Brun SN; Kamireddy A; Svensson RU; Vera LI; Ross DS; Rymoff TJ; Hutchins A; Galvez HM; Williams AE; Shokhirev MN; Screaton RA; Berdeaux R; Shaw RJ
    Cancer Discov; 2019 Nov; 9(11):1606-1627. PubMed ID: 31350328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
    Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
    PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53/Lactate dehydrogenase A axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild-type p53.
    Zhou Y; Niu W; Luo Y; Li H; Xie Y; Wang H; Liu Y; Fan S; Li Z; Xiong W; Li X; Ren C; Tan M; Li G; Zhou M
    Cancer Sci; 2019 Mar; 110(3):939-949. PubMed ID: 30618169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salt-inducible kinase 2 and -3 are downregulated in adipose tissue from obese or insulin-resistant individuals: implications for insulin signalling and glucose uptake in human adipocytes.
    Säll J; Pettersson AM; Björk C; Henriksson E; Wasserstrom S; Linder W; Zhou Y; Hansson O; Andersson DP; Ekelund M; Degerman E; Stenkula KG; Laurencikiene J; Göransson O
    Diabetologia; 2017 Feb; 60(2):314-323. PubMed ID: 27807598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diverse oncogenic and tumor suppressor roles of salt-inducible kinase (SIK) in cancer.
    Du WQ; Zheng JN; Pei DS
    Expert Opin Ther Targets; 2016; 20(4):477-85. PubMed ID: 26549013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant p53 and mTOR/PKM2 regulation in cancer cells.
    Dando I; Cordani M; Donadelli M
    IUBMB Life; 2016 Sep; 68(9):722-6. PubMed ID: 27385486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIKs suppress tumor function and regulate drug resistance in breast cancer.
    Xin L; Liu C; Liu Y; Mansel RE; Ruge F; Davies E; Jiang WG; Martin TA
    Am J Cancer Res; 2021; 11(7):3537-3557. PubMed ID: 34354859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 14-3-3 proteins mediate inhibitory effects of cAMP on salt-inducible kinases (SIKs).
    Sonntag T; Vaughan JM; Montminy M
    FEBS J; 2018 Feb; 285(3):467-480. PubMed ID: 29211348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STK25-induced inhibition of aerobic glycolysis via GOLPH3-mTOR pathway suppresses cell proliferation in colorectal cancer.
    Wu F; Gao P; Wu W; Wang Z; Yang J; Di J; Jiang B; Su X
    J Exp Clin Cancer Res; 2018 Jul; 37(1):144. PubMed ID: 29996891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salt-inducible kinase (SIK) isoforms: their involvement in steroidogenesis and adipogenesis.
    Katoh Y; Takemori H; Horike N; Doi J; Muraoka M; Min L; Okamoto M
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):109-12. PubMed ID: 15134808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.
    Makinoshima H; Takita M; Saruwatari K; Umemura S; Obata Y; Ishii G; Matsumoto S; Sugiyama E; Ochiai A; Abe R; Goto K; Esumi H; Tsuchihara K
    J Biol Chem; 2015 Jul; 290(28):17495-504. PubMed ID: 26023239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis.
    Cheng H; Liu P; Wang ZC; Zou L; Santiago S; Garbitt V; Gjoerup OV; Iglehart JD; Miron A; Richardson AL; Hahn WC; Zhao JJ
    Sci Signal; 2009 Jul; 2(80):ra35. PubMed ID: 19622832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salt-inducible kinase 1 (SIK1) is induced by gastrin and inhibits migration of gastric adenocarcinoma cells.
    Selvik LK; Rao S; Steigedal TS; Haltbakk I; Misund K; Bruland T; Prestvik WS; Lægreid A; Thommesen L
    PLoS One; 2014; 9(11):e112485. PubMed ID: 25384047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cAMP-elevation mediated by β-adrenergic stimulation inhibits salt-inducible kinase (SIK) 3 activity in adipocytes.
    Berggreen C; Henriksson E; Jones HA; Morrice N; Göransson O
    Cell Signal; 2012 Sep; 24(9):1863-71. PubMed ID: 22588126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor cells switch to mitochondrial oxidative phosphorylation under radiation via mTOR-mediated hexokinase II inhibition--a Warburg-reversing effect.
    Lu CL; Qin L; Liu HC; Candas D; Fan M; Li JJ
    PLoS One; 2015; 10(3):e0121046. PubMed ID: 25807077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salt-inducible Kinases Are Critical Determinants of Female Fertility.
    Armouti M; Winston N; Hatano O; Hobeika E; Hirshfeld-Cytron J; Liebermann J; Takemori H; Stocco C
    Endocrinology; 2020 Jul; 161(7):. PubMed ID: 32343771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AKT Blocks SIK1-Mediated Repression of STAT3 to Promote Breast Tumorigenesis.
    Sun Z; Jiang Q; Gao B; Zhang X; Bu L; Wang L; Lin Y; Xie W; Li J; Guo J
    Cancer Res; 2023 Apr; 83(8):1264-1279. PubMed ID: 36806887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.